Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1981-04-24
1983-09-06
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424330, A61K 3122, A61K 31135
Patent
active
044029764
ABSTRACT:
A method is provided for treating glaucoma by systemic administration of nadolol or esters of nadolol.
REFERENCES:
patent: 3935267 (1976-01-01), Hauck et al.
patent: 3982021 (1976-09-01), Hauck et al.
patent: 4029676 (1977-06-01), Hauck et al.
patent: 4275074 (1981-06-01), Langham
patent: 4346106 (1982-08-01), Sudilovsky
Batchelor et al., "Interaction of Topical and Oral Timolol in Glaucoma" Ophthamology, 86:60-65, 1979.
Cote et al., "The Effect of Propranolol on Human Intraocular Pressure" Canad. J. Ophthal., 3:207, 1968.
Wettrell et al., "Beta-Adrenoceptor Blocking Agents in the Management of Glaucoma" Bellows Glaucoma Contemporary International Concepts, Chapter 23, pp. 367-375.
E. R. Squibb & Sons Inc.
Levinson Lawrence S.
Robinson Douglas W.
Rodney Burton
LandOfFree
Method for treating glaucoma with systemic nadolol compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating glaucoma with systemic nadolol compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating glaucoma with systemic nadolol compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1592316